Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Herpes zoster, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: difficulty standing or walking; Numbness; pain; Tingling; itching; shingles outbreak on my arm and leg; even more significant spike of the neuralgia; This spontaneous case was reported by a consumer and describes the occurrence of POST HERPETIC NEURALGIA (even more significant spike of the neuralgia), GAIT DISTURBANCE (difficulty standing or walking), HYPOAESTHESIA (Numbness), PAIN (pain) and HERPES ZOSTER (shingles outbreak on my arm and leg) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Post herpetic neuralgia (in left leg since 5 years ago) in 2016. Previously administered products included for Drug use for unknown indication: tetanus vaccine, Lidocaine (Itch bumps) and Sulfa. Past adverse reactions to the above products included Hives with Sulfa and tetanus vaccine; and Itch with Lidocaine. Concurrent medical conditions included Shingles (Recurrent shingles) since 1969, Chemical sensitivity (Swelling due to Spermicide) and Shingles (Recurrent shingles) in 1970. Concomitant products included LOSARTAN for Blood pressure, TRAZODONE and MELATONIN for Sleep deficit, ESTRADIOL for Vaginal dryness, VITAMIN D NOS and CYANOCOBALAMIN (B-12) for Vitamin deficiency.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced POST HERPETIC NEURALGIA (even more significant spike of the neuralgia). On 08-Apr-2021, the patient experienced HERPES ZOSTER (shingles outbreak on my arm and leg). On an unknown date, the patient experienced GAIT DISTURBANCE (difficulty standing or walking), HYPOAESTHESIA (Numbness), PAIN (pain), PARAESTHESIA (Tingling) and PRURITUS (itching). The patient was treated with VALACYCLOVIR [VALACICLOVIR] ongoing since an unknown date for Shingles, at an unspecified dose and frequency. At the time of the report, POST HERPETIC NEURALGIA (even more significant spike of the neuralgia) had not resolved, GAIT DISTURBANCE (difficulty standing or walking), HYPOAESTHESIA (Numbness), PAIN (pain), PARAESTHESIA (Tingling) and PRURITUS (itching) outcome was unknown and HERPES ZOSTER (shingles outbreak on my arm and leg) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that she had a significant spike in the neuralgia severe enough to warrant a call to the primary care physician where she prescribed a course of steroids which unfortunately did not help.  Concomitant medication included steroids. The follow-up form noted the shingles in the initial source document as recovered.   This case was linked to MOD-2021-115844 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2021: Significant follow up was added On 13-Jun-2021: Follow-up information was received on 13-Jun-2021: Second dose added and action taken updated.